Bioequivalence standards for generic drugs have long ignored batch-to-batch variability, risking false conclusions. New guidelines now require multi-batch testing to ensure real-world equivalence and patient safety.
Jan, 26 2026
Sep, 30 2025
Oct, 25 2025
Oct, 17 2025
Oct, 9 2025